Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-083980
Filing Date
2015-12-08
Accepted
2015-12-08 16:30:11
Documents
1
Period of Report
2015-12-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4138
  Complete submission text file 0001209191-15-083980.txt   5492
Mailing Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Issuer) CIK: 0001598646 (see all company filings)

EIN.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address
Luthringer Remy (Reporting) CIK: 0001610384 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36517 | Film No.: 151275943